Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Upadacitinib
Upadacitinib
1310726-60-3
|
380.157
|
2.262
Upadacitinib is an oral selective inhibitor of tyrosine-protein kinase JAK1 and a disease-modifying antirheumatic drug. It is used in the treatment of rheumatoid arthritis to slow down disease progression.
ABT-494 | upadacitinib
Upadacitinib is an oral selective inhibitor of tyrosine-protein kinase JAK1 and a disease-modifying antirheumatic drug. It is used in the treatment of rheumatoid arthritis to slow down disease progression.
ABT-494 | upadacitinib
$141/5 mg
(EBC)
1
CAS:1607431-21-9
0
CAS:2050057-56-0
0
We provide 0 compound for Upadacitinib